E. Camela, “Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire”, Dermatol Pract Concept, vol. 13, no. 3, p. e2023177, Jul. 2023, doi: 10.5826/dpc.1303a177.